Position in MRK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$66,465,340
+$4,595,382 QoQ
Shares Held
517,240
+0.6% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
2.75%
of 13F equity value
Holder Rank
#268
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RNC CAPITAL MANAGEMENT LLC holds $281,592,319 across 11 Drug Manufacturers - General names. MRK ranks #1 (23.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
517,240 | $66,465,340 | |
| 2 | ABBV |
AbbVie Inc.
|
236,727 | $59,569,982 | |
| 3 | JNJ |
Johnson & Johnson
|
191,013 | $48,511,571 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
356,290 | $45,013,678 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
645,383 | $37,186,968 | |
| 6 | LLY |
ELI LILLY & Co
|
13,549 | $16,251,078 | |
| 7 | AZN |
Astrazeneca PLC
|
32,535 | $6,169,286 | |
| 8 | AMGN |
Amgen Inc
|
2,755 | $997,640 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,465,340 | 517,240 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $61,869,958 | 514,340 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $53,220,613 | 505,611 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $42,372,060 | 504,850 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $29,409,839 | 371,524 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $35,337,345 | 393,687 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $28,639,197 | 287,889 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $3,290,855 | 28,979 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,587,600 | 28,979 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,466,062 | 26,268 | Shares | Sole | 2024-08-07 | |
| 2023-12-31 | $2,345,565 | 21,515 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $2,806,931 | 27,265 | Shares | Sole | 2023-12-27 | |
| 2023-06-30 | $3,247,766 | 28,146 | Shares | Defined | 2023-07-21 | |
| 2023-03-31 | $901,868 | 8,477 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $922,105 | 8,311 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $761,473 | 8,842 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $841,043 | 9,225 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $768,972 | 9,372 | Shares | Sole | 2022-07-22 | |
| 2021-12-31 | $800,274 | 10,442 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $694,241 | 9,243 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $746,125 | 9,594 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $739,601 | 9,594 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,103,317 | 13,488 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $1,262,001 | 15,214 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $1,229,006 | 15,893 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $1,244,965 | 16,181 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||